Lv52
1310 积分 2025-10-10 加入
Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials
10分钟前
待确认
Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2)
28分钟前
待确认
Long-Term Outcomes of Elagolix in Women With Endometriosis
58分钟前
待确认
Prolonged oral GnRH-antagonist administration before euploid embryo transfer in patients with endometriosis: a prospective randomized pilot non-inferiority trial
6天前
已关闭
Elagolix Represents a Less Invasive and Cheaper Option Than Injectable GnRH Antagonist for Ovulation Suppression in IVF
6天前
已完结
Subchorionic hemorrhage treatment with dydrogesterone
11天前
已完结
Follicle-Stimulating Hormone Glycobiology
13天前
已完结
O-188 Serum progesterone on day of frozen embryo transfer (FET), including non-rescued patients with low progesterone, does not impact outcome: a prospective analysis and randomized trial
14天前
已关闭
PROGESTERONE AND 20α-DIHYDROPROGESTERONE IN HUMAN MYOMETRIUM DURING PREGNANCY
1个月前
已完结
Suppression of Gonadotropins and Estradiol in Premenopausal Women by Oral Administration of the Nonpeptide Gonadotropin-Releasing Hormone Antagonist Elagolix
1个月前
已完结
皖公网安备34019202002308
